On successful inspection by USFDA
Caplin Point has received the Establishment Inspection Report from USFDA for the inspection carried out during 21 October - 27 October, 2016 at its sterile injectable plant at Gummidipoondi, Tamil Nadu.The facility, capable of manufacturing liquid injectables in vials, ampoules, lyophilized vials and ophthalmic dosages, is approved by EU-GMP and ANVISA-Brasil.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
